Lymphoma Diagnosis and Treatment

Lymphoma encompasses a broad family of cancers arising from lymphoid cells, and distinguishing between its many subtypes—from Hodgkin's lymphoma to diffuse large B-cell lymphoma to rarer T-cell variants—is essential because each carries distinct biology, prognosis, and treatment requirements. Researchers study how disruptions in B-cell receptor signaling, chromosomal translocations, and other genetic events drive malignant transformation, and they use tools like gene expression profiling and PET imaging to classify tumors more precisely and predict which patients will respond to therapies such as rituximab. A central open question is why patients with apparently similar diagnoses under conventional pathology can have dramatically different outcomes, pushing investigators toward molecular stratification that goes deeper than histology alone. Active work is also focused on identifying resistance mechanisms to existing targeted therapies and on determining how to sequence or combine immunotherapy, chemotherapy, and novel agents for the subtypes that remain hardest to treat.

Works

133,349

Total citations

1,994,830

Keywords

LymphomaClassificationMolecular ProfilingRituximabGenetic PathogenesisPET Imaging